* Hyperfine Inc HYPR.OQ reported a quarterly adjusted loss
of 14
cents per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of -15
cents. The mean expectation of three analysts for the quarter
was for a loss of 14 cents per share. Wall Street expected
results to range from -15 cents to -13 cents per share.
* Revenue rose 7.4% to $3.63 million from a year ago;
analysts
expected $3.26 million.
* Hyperfine Inc's reported EPS for the quarter was a loss
of 14
cents.
* The company reported a quarterly loss of $10.16 million.
* Hyperfine Inc shares had risen by 29.4% this quarter and
lost 1.8% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 5% in
the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Hyperfine Inc is
$1.30
This summary was machine generated from LSEG data August 9 at
06:32 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.14 -0.14 Met
Mar. 31 2024 -0.15 -0.14 Beat
Dec. 31 2023 -0.18 -0.15 Beat
Sep. 30 2023 -0.16 -0.15 Beat